Presented here is a protocol for the separation of epidermis from dermis to evaluate inflammatory mediator production. Following inflammation, rat hind paw epidermis is separated from the dermis by thermolysin at 4 °C. The epidermis is then used for mRNA analysis by RT-PCR and protein evaluation by western blot and immunohistochemistry.
Easy-to-use and inexpensive techniques are needed to determine the site-specific production of inflammatory mediators and neurotrophins during skin injury, inflammation, and/or sensitization. The goal of this study is to describe an epidermal-dermal separation protocol using thermolysin, a proteinase that is active at 4 °C. To illustrate this procedure, Sprague Dawley rats are anesthetized, and right hind paws are injected with carrageenan. Six and twelve hours after injection, rats with inflammation and naïve rats are euthanized, and a piece of hind paw, glabrous skin is placed in cold Dulbecco’s Modified Eagle Medium. The epidermis is then separated at the basement membrane from the dermis by thermolysin in PBS with calcium chloride. Next, the dermis is secured by microdissection forceps, and the epidermis is gently teased away. Toluidine blue staining of tissue sections show that the epidermis is separated cleanly from the dermis at the basement membrane. All keratinocyte cell layers remain intact, and the epidermal rete ridges along with indentations from dermal papillae are clearly observed. Qualitative and real-time RT-PCR is used to determine nerve growth factor and interleukin-6 expression levels. Western blotting and immunohistochemistry are finally performed to detect amounts of nerve growth factor. This report illustrates that cold thermolysin digestion is an effective method to separate epidermis from dermis for evaluation of mRNA and protein alterations during inflammation.
Evaluation of inflammatory mediators and neurotrophic factors from the skin can be limited due to the heterogeneity of cell types found in the inflamed dermis and epidermis1,2,3. Several enzymes, chemical, thermal, or mechanical techniques involving separation of the two layers or for performing cell dissociation for evaluation have been reviewed recently4. Acid, alkali, neutral salt, and heat can divide the epidermis from dermis quickly, but cellular and extracellular swelling often occurs5,6. Trypsin, pancreatin, elastase, keratinase, collagenase, pronase, dispase, and thermolysin are enzymes that have been used for epidermal-dermal separation4,7. Trypsin and other broad scale proteolytic enzymes are active at 37–40 °C but must be monitored carefully to prevent dissociation of epidermal layers. Dispase cleaves the epidermis at the lamina densa, but requires 24 h for separation in the cold4,8 or shorter timepoints at 37 °C4,9. A limiting feature of all these techniques is the potential disruption of tissue morphology and loss of integrity of mRNA and protein.
To maintain the integrity of mRNA and protein, a skin separation method should be carried out in the cold for a short period of time. In evaluating skin separation techniques for inflammation studies, thermolysin is an effective enzyme to separate the epidermis from dermis at cold temperatures4. Thermolysin is active at 4 °C, cleaves epidermal hemidesmosomes from the lamina lucida, and separates the epidermis from dermis within 1–3 h4,8,10. The goal of this report is to optimize the use of thermolysin for separation of inflamed rat epidermis from dermis to detect mRNA and protein levels for inflammatory mediators and neurotrophic factors. Several preliminary reports have been presented11,12,13,14,15. The objective of this manuscript is to describe an optimal skin separation technique using thermolysin and demonstrate the detection of 1) markers of inflammation, 2) interleukin-6 (IL-6) mRNA, and 3) nerve growth factor (NGF) mRNA and protein in the epidermis of rats with carrageenan-induced inflammation (C-II)16,17. A preliminary report using the complete Freund’s adjuvant model indicates that NGF mRNA and protein levels increase early during inflammation15. In mice, skin sensitization with the topical application of oxazolone causes an early rise in the IL-6 mRNA using in situ hybridization36. Both IL-6 and NGF have been implicated in C-II18,19, but there have been no reports describing mRNA or protein levels for IL-6 or NGF specifically from the epidermis during the acute stages of C-II.
The thermolysin technique is inexpensive and straightforward to perform. Furthermore, thermolysin separation of the epidermis from dermis allows for mRNA, western blot, and immunohistochemical analysis of inflammatory mediators and neurotrophic factors during the process of inflammation15. Investigators should be able to easily use this technique in both preclinical and clinical studies of skin inflammation.
This protocol follows the animal care guidelines of Oklahoma State University Center for Health Sciences IACUC (#2016-03).
1. Carrageenan-induced inflammation (C-II)
2. Thermolysin separation of epidermis and dermis
3. Protein extraction and western blot analysis
4. Immunohistochemistry
5. RNA isolation and cDNA synthesis
Carrageenan injection into the rat hind paw caused classic symptoms of inflammation such as redness and edema16,17. The swelling of the hind paw was measured with mechanical calipers20. A baseline value of the thickness of the paw was obtained for each rat before carrageenan treatment and measured again at 6 h and 12 h. Paw thickness was increased significantly compared to the baseline values (Figure 1).
Thermolysin incubation of the rat glabrous hind paw skin produced a sheet of epidermis. Brightfield microscopy was used to evaluate the effectiveness of thermolysin separation of the epidermis and dermis (Figure 2). The layers of the epidermis could be determined while focusing through the sheet at higher magnification. Toluidine blue staining of epidermal cross sections showed that the epidermis was separated from the dermis at the basement membrane (Figure 3). The epidermal rete ridges (epidermal pegs) along with the indentations from dermal papillae were intact. All keratinocyte cell layers were observed.
Western blotting of thermolysin-separated epidermis produced consistent results indicating stable protein levels during the technique at 4 °C. Very little NGF protein was detected in naïve rat epidermis, but NGF protein levels were upregulated (250%) after 6 h of C-II as compared to naïve animals (Figure 4). After 12 h of C-II, NGF levels were reduced compared to 6 h but remained elevated (55%) relative to controls. Immunohistochemistry for NGF in the separated epidermis provided reliable immunostaining and confirmed the results from western blots (Figure 5). NGF-immunoreactivity (ir) was not detected in naïve control epidermis, but at 6 h C-II, there was NGF-ir in most of the keratinocytes of the stratum granulosum and stratum lucidum. A few cells for the stratum spinosum were NGF-immunoreactive (IR) at 6 h C-II. At 12 h C-II, NGF-ir occurred in keratinocytes of the stratum granulosum and stratum lucidum with some cells in stratum granulosum intensely NGF-IR. At no timepoint was NGF-ir detected in stratum basale or stratum corneum. PGP9.5-IR intraepidermal, varicose nerve fibers were present in the separated epidermis from naïve and C-II rats (Figure 5).
Qualitative RT-PCR demonstrated that there was good quality mRNA from thermolysin-separated epidermis (Figure 6A, Figure 7A). Using actin as a housekeeping gene for quantitative real-time PCR, NGF mRNA expression in epidermis during C-II was significantly elevated (>3-fold) at 6 h compared to naïve rats (Figure 6B). At 12 h, NGF mRNA returned to baseline levels (Figure 6B). Using actin as a housekeeping gene for quantitative real-time PCR, IL-6 mRNA in epidermis during C-II was significantly elevated (>6-fold) at 6 h compared to naïve rats (Figure 7B). At 12 h, IL-6 mRNA levels dropped significantly from the 6 h amounts but remained elevated (2-fold) compared to naïve rats (Figure 7B).
Figure 1: Carrageenan injection produces paw edema.
A baseline value was obtained for each rat prior to carrageenan treatment. After 6 h and 12 h of treatment, paw thickness increased significantly compared to baseline values. The results are expressed as the SEM with six rats per treatment (*p < 0.05, **p < 0.01, ***p < 0.001; student’s t-test, unpaired, two-tail, was performed at each timepoint). Please click here to view a larger version of this figure.
Figure 2: Thermolysin produces a sheet of epidermis.
Brightfield microscopy revealed a translucent epidermal sheet approximately 1 mm x 2 mm in size. The layers of the epidermis could be determined while focusing through the sheet at higher magnification. Scale bar = 500 µm. Please click here to view a larger version of this figure.
Figure 3: Toluidine blue staining of the epidermis.
Brightfield microscopy determined that thermolysin caused an effective separation of the epidermis from dermis. Epidermal rete ridges (epidermal pegs; arrowheads) were observed along with indentations from dermal papillae (arrows). All keratinocyte cell layers were intact. SB: stratum basale, SS: stratum spinosum, SG: stratum granulosum, SL: stratum lucidum, SC: stratum corneum. Scale bar = 100 µm. Please click here to view a larger version of this figure.
Figure 4: NGF protein expression in epidermis during carrageenan-induced inflammation.
NGF levels were increased (250%) after 6 h of inflammation compared to naïve animals. After 12 h, the levels were reduced compared to 6 h but were elevated (55%) in contrast to naïve animals. The results are expressed as the SEM with three rats per group (*p < 0.05, **p < 0.01, ***p < 0.001; student’s t-test, unpaired, two-tail was performed at each timepoint) Please click here to view a larger version of this figure.
Figure 5: NGF and PGP9.5 immunoreactivity (ir) during C-II.
Columns A,B,C show NGF-ir, PGP9.5-ir, and DAPI nuclear staining, whereas columns A1-C1 show only NGF-ir. In all images, stratum corneum is towards the left and stratum basale towards the right. NGF-ir was not detected in naïve control epidermis (A, A1). At 6 h C-II (B,B1), NGF-ir was present in most keratinocytes of the stratum granulosum (short arrows) and stratum lucidum (long arrows). A few cells for the stratum spinosum were NGF-ir at 6 h C-II (large arrowheads). At 12 h C-II (C,C1), NGF-ir occurred in keratinocytes of the stratum granulosum and stratum lucidum (long arrows) with some cells in stratum granulosum intensely NGF-ir (short arrows). At no timepoint was NGF-ir detected in stratum basale or stratum corneum. PGP9.5-ir intraepidermal nerve fibers were present in the separated epidermis from naïve and C-II rats (small arrowheads, A-C). SB: stratum basale, SS: stratum spinosum, SG: stratum granulosum, SL: stratum lucidum. Scale bar = 50 µm. Please click here to view a larger version of this figure.
Figure 6: NGF mRNA during carrageenan-induced inflammation.
NGF mRNA expression in thermolysin-separated epidermis during C-II was evaluated by qualitative PCR (A) and quantitative real-time PCR (B). Qualitative mRNA blots (A) for NGF and actin demonstrated that there was good quality mRNA that could be evaluated during inflammation. NGF mRNA expression in epidermis during C-II was evaluated by quantitative real time PCR using actin as a housekeeping gene (B). NGF mRNA was significantly elevated (>3-fold) after 6 h of C-II compared to naïve untreated rats, but levels returned to baseline at 12 h (B). Results are expressed as the SEM with three rats per group (*p < 0.05, **p < 0.01, ***p < 0.001; student’s t-test, unpaired, two-tail was performed at each timepoint). Please click here to view a larger version of this figure.
Figure 7: IL-6 mRNA during carrageenan-induced inflammation.
IL-6 mRNA expression in thermolysin-separated epidermis during C-II was evaluated by qualitative PCR (A) and quantitative real-time PCR (B). Qualitative mRNA blots (A) for IL-6 and actin showed there was good quality mRNA for evaluation during inflammation. IL-6 mRNA expression in epidermis during C-II was evaluated by quantitative real-time PCR using actin as a housekeeping gene (B). IL-6 mRNA was significantly elevated (>6-fold) after 6 h of C-II compared to naïve untreated rats (B). At 12 h, IL-6 mRNA levels were reduced significantly from 6 h levels but remained elevated (2-fold) compared to naïve rats (B). Results are expressed as the mean S.E.M. with two rats per group (*p < 0.05, **p < 0.01, ***p < 0.001, student’s t-test, unpaired, two-tail was performed at each timepoint). Please click here to view a larger version of this figure.
The study determined that the epidermis of rat hind paw glabrous skin was easily separated from dermis using thermolysin (0.5 mG/mL) in PBS with 1 mM calcium chloride at 4 °C for 2.5 h. Histological evaluation indicated that the epidermis was separated from the dermis at the basement membrane and that the epidermal rete ridges were intact. Thermolysin is an extracellular metalloendopeptidase produced by Gram-positive (Geo)Bacillus thermoproteolyticus24. Its activity is stable at 4 °C but is functional over a wide range of temperatures10,24,25. This enzyme has been used extensively for protein chemistry24,25, but several groups have shown its application for skin separation into epidermal and/or dermal sheets4,8,10,26,27. Walzer et al. were the first to report epidermal-dermal separation of human skin using thermolysin at 4 °C (250–500 μg/mL for 1 h)10. With light and electron microscopy, separation was determined to occur at the epidermal basement membrane between laminin and the bullous pemphigoid antigen site10.
Furthermore, hemidesmosomes, the attachments of basal keratinocytes to the basement membrane, were disrupted selectively10,29. Rakhorst et al. compared thermolysin (4 °C, 500 µg/mL, overnight) to dispase for epidermal-dermal separation of rabbit buccal mucosa8. Thermolysin was incomplete in separating the mucosal epidermis from dermis signifying that differences may occur for species, incubation time, solution composition (no CaCl2 to prevent thermolysin autolysis24), source of thermolysin, and/or site-specific differences indicated from other studies10,26,27. End users of the current protocol should make sure to use fresh thermolysin and always include calcium chloride but also should be aware of these potential limitations.
Although some investigators have used thermolysin at 37 °C26,29, users of this protocol should be mindful to keep skin tissue at 4 °C to preserve the stability of protein and mRNA. We used DMEM at 4 °C as a solution for skin prior to and after thermolysin separation because of its usefulness in maintaining cells in culture28, and it has been used previously for skin separation with thermolysin8,26,27,30,31. However, Walzer et al. used sterile PBS supplemented with 200 µG/mL streptomycin, 200 U/mL penicillin, and 2.5 µg/mL fungizone10, whereas others have used different media (e.g., keratinocyte culture media free of epidermal growth factor) followed by PBS rinsing29.
In the protocol, thermolysin separation was performed in 500 µg/mL thermolysin and 5 mM calcium chloride in PBS (pH = 8), similar to the original method10. DMEM has been used as a solution for thermolysin separation at 4 °C (overnight)8, and HEPES buffer has been used effectively with 500 μG/mL thermolysin solution at 37 °C for 2 h29. However, we did not explore how culture medium or other buffers affects thermolysin’s activity for epidermal-dermal separation. Calcium chloride is an important addition to decrease autolysis of thermolysin24,32 and deletion of this step may lead to incomplete cleavage of the epidermis from dermis8.
The size of the skin sample appears to influence the time needed for thermolysin incubation and the effectiveness of enzymatic cleavage of the epidermis from dermis. Investigators need to evaluate the appropriate sample size and incubation time for their own tissues. Floating the samples on the thermolysin solution with the epidermis facing upward is important for optimal enzyme effectiveness10. As noted earlier, the site of action for thermolysin is at the keratinocyte hemidesmosomes and basement membrane4,10,29; therefore, thermolysin works inward from the edges of the skin. From our experience, the skin edges separate earlier than the middle of the sample, and it is important to allow enough time for complete enzymatic cleavage. When cleavage is complete, the epidermis should pull away easily from the dermis. If still attached, tugging on the layers may cause portions of dermis to come away with the epidermis.
A limitation of the thermolysin technique is the time required. Increasing the thermolysin concentration beyond 500 µG/mL does not decrease the time for separation and there is poor preservation of the epidermis at higher concentrations10. Epidermal-dermal separation methods have been reviewed recently4, and many methods take 30–60 min at 20–40 °C. Heat (50–60 °C) separation of skin occurs quickly (30 s to 10 min)4, but proteins and mRNA are known to degrade quickly at such high temperatures. Alternatively, sodium thiocyanate (2 N) at RT may be an acceptable rapid separation technique (5 min)4,6, but protein and mRNA integrity have not been studied with this method6. The cold thermolysin method was chosen for the preservation of protein and mRNA, but there were no direct comparisons made between protein and mRNA integrity using other techniques.
In the present study, cold thermolysin digestion is demonstrated to be an effective method to separate the epidermis from the dermis for evaluation of mRNA and protein alterations during inflammation. During carrageenan-induced inflammation, NGF mRNA and protein levels and IL-6 mRNA levels were elevated at 6 h, returning close to baseline by 12 h. With immunohistochemistry, NGF immunoreactivity was increased in keratinocytes at 6 h and 12 h. An advantage of the thermolysin method is the ability to perform site-selective analysis. For example, the increased production of NGF and IL-6 in the current study is from keratinocytes, since dermal cells are excluded from the assays. This method allows for insight into the location and mediator types for sensitization of primary afferent terminals33. In addition, this method allows for better understanding of the time course of neurotrophin production along with uptake and transport in primary afferents during inflammation34,35.
The authors have nothing to disclose.
Funding for this research was provided by National Institutes of Health NIH-AR047410 (KEM)
λ-carrageenan | Millipore Sigma | 22049 | Subcutaneous injection of carrageenan induces inflammation |
7500 Fast Real-Time PCR System | Thermo Fisher Scientific | 4351107 | For RT-PCR analysis |
Calcium chloride (CaCl2), anhydrous | Millipore Sigma | 499609 | Prevents autolysis of thermolysin |
Crystal Mount Aqueous Mounting Medium | Millipore Sigma | C0612 | Aqueous mounting medium after toluidine blue staining |
Donkey anti-Mouse Alexa Fluor 555 | Thermo Fisher Scientific | A-31570 | Secondary antibody for immunohistochemistry |
Donkey anti-Rabbit IgG, Alexa Fluor 488 | Thermo Fisher Scientific | A-21206 | Secondary antibody for immunohistochemistry |
Dulbecco's Modified Eagle Medium | Thermo Fisher Scientific | 11966-025 | To maintain tissue integrity |
Ethylenediaminetetraacetic acid | Millipore Sigma | E6758 | Stops thermolysin reaction |
Moloney Murine Leukemia Virus (M-MLV) Reverse transcriptase | Promega | M1701 | For complementary DNA synthesis |
Mouse anti-NGF Antibody (E-12) | Santa Cruz Biotechnology | sc-365944 | For neurotrophin immunohistochemistry |
ProLong Gold Antifade Mountant | Thermo Fisher Scientific | P36930 | To retard immunofluorescence quenching |
Rabbit anti-PGP 9.5 | Cedarlane Labs | CL7756AP | For intraepidermal nerve staining |
SAS Sprague Dawley Rat | Charles River | Strain Code 400 | Animal used for inflammation studies |
Shandon M-1 Embedding Matrix | Thermo Fisher Scientific | 1310TS | Tissue embedding matrix for tinctorial- and immuno-histochemistry |
SimpliAmp Thermal Cycler | Thermo Fisher Scientific | A24811 | For RT-PCR analysis |
SYBR Select Master Mix | Thermo Fisher Scientific | 4472908 | For RT-PCR analysis |
Thermolysin | Millipore Sigma | T7902 | From Geobacillus stearothermophilus |
Toluidine Blue | Millipore Sigma | 89640 | For tinctorial staining for brightfield microscopy |
TRIzol Reagent | Thermo Fisher Scientific | 15596026 | For total RNA extraction for RTPCR |